Literature DB >> 24334218

Alopecia areata developing during ustekinumab therapy: report of two cases.

Marie Tauber1, Nathalie Beneton2, Pascal Reygagne3, Hervé Bachelez1, Manuelle Viguier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24334218     DOI： 10.1684/ejd.2013.2221

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  8 in total

1.  IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.

Authors:  Luana S Ortolan; Sa Rang Kim; Sydney Crotts; Lucy Y Liu; Brittany G Craiglow; Carlos Wambier; Renato S Paschoal; Brett A King; Ali Jabbari
Journal:  J Allergy Clin Immunol       Date:  2019-08-27       Impact factor: 10.793

Review 2.  The continuing evolution of targeted therapy for inflammatory skin disease.

Authors:  C Schlapbach; A A Navarini
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

Review 3.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

Review 4.  The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.

Authors:  Yael Renert-Yuval; Emma Guttman-Yassky
Journal:  Adv Ther       Date:  2017-06-23       Impact factor: 3.845

5.  Comparison of serum concentrations of interleukins 10, 12, 17 and 35 between patients with alopecia areata and controls.

Authors:  Marta Wojciechowska-Zdrojowy; Alina Jankowska-Konsur; Danuta Nowicka-Suszko; Jacek C Szepietowski; Anita Hryncewicz-Gwóźdź
Journal:  Postepy Dermatol Alergol       Date:  2022-01-07       Impact factor: 1.837

6.  Transient Efficacy of Tofacitinib in Alopecia Areata Universalis.

Authors:  Florian Anzengruber; Julia-Tatjana Maul; Jivko Kamarachev; Ralph M Trüeb; Lars E French; Alexander A Navarini
Journal:  Case Rep Dermatol       Date:  2016-04-22

7.  Alopecia areata after denosumab treatment for osteoporosis.

Authors:  Anna Lyakhovitsky; Shlomit Oshinsky; Sarit Gilboa; Aviv Barzilai
Journal:  JAAD Case Rep       Date:  2016-08-01

Review 8.  Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review.

Authors:  Jo L W Lambert; Sofie De Schepper; Reinhart Speeckaert
Journal:  J Clin Med       Date:  2021-03-03       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.